B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)

REACTOME PATHWAY
Reactome: R-HSA-9759574 genes18 compounds

The Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) pathway (Reactome ID: R-HSA-975957) involves 4 genes and is affected by 18 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

EIF4G1PABPC1PPP2CARPSA

Compounds Affecting Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)

#CompoundTargets HitStudies
1egcg300
2Hexachlorophene300
3Oxytetracycline300
4Oxcarbazepine296
5Rosmarinic Acid300
6Rutin300
7Anthralin299
8Cefixime300
9Ethidium300
10Phenoxybenzamine21
11sp600125117
12Temozolomide299
13DEAD-box RNA Helicases169
14Thioctic Acid298
15Thioctic Acid300
16Azauridine300
17Levetiracetam296
18Okadaic Acid300

About the Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) Pathway

The Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) pathway is catalogued in Reactome (ID: R-HSA-975957) and involves 4 genes. In the BiohacksAI corpus, 18 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include EIF4G1, PABPC1, PPP2CA, RPSA.